Calton & Associates’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-2,570
| Closed | -$205K | – | 192 |
|
|
2024
Q1 | $205K | Sell |
2,570
-1,821
| -41% | -$145K | 0.1% | 180 |
|
|
2023
Q4 | $347K | Buy |
+4,391
| New | +$347K | 0.14% | 147 |
|
|
2023
Q3 | – | Sell |
-4,261
| Closed | -$295K | – | 137 |
|
|
2023
Q2 | $295K | Buy |
4,261
+925
| +28% | +$63.9K | 0.14% | 146 |
|
|
2023
Q1 | $248K | Sell |
3,336
-1,071
| -24% | -$79.6K | 0.12% | 178 |
|
|
2022
Q4 | $411K | Buy |
4,407
+1,411
| +47% | +$131K | 0.16% | 152 |
|
|
2022
Q3 | $285K | Sell |
2,996
-345
| -10% | -$32.8K | 0.16% | 143 |
|
|
2022
Q2 | $309K | Sell |
3,341
-1,034
| -24% | -$95.6K | 0.17% | 145 |
|
|
2022
Q1 | $442K | Sell |
4,375
-687
| -14% | -$69.4K | 0.13% | 186 |
|
|
2021
Q4 | $522K | Sell |
5,062
-2,078
| -29% | -$214K | 0.14% | 171 |
|
|
2021
Q3 | $605K | Buy |
7,140
+882
| +14% | +$74.7K | 0.13% | 176 |
|
|
2021
Q2 | $520K | Sell |
6,258
-147
| -2% | -$12.2K | 0.1% | 191 |
|
|
2021
Q1 | $482K | Sell |
6,405
-864
| -12% | -$65K | 0.09% | 186 |
|
|
2020
Q4 | $497K | Buy |
7,269
+402
| +6% | +$27.5K | 0.09% | 182 |
|
|
2020
Q3 | $401K | Buy |
6,867
+3,104
| +82% | +$181K | 0.08% | 186 |
|
|
2020
Q2 | $245K | Buy |
3,763
+316
| +9% | +$20.6K | 0.05% | 259 |
|
|
2020
Q1 | $205K | Sell |
3,447
-877
| -20% | -$52.2K | 0.05% | 267 |
|
|
2019
Q4 | $321K | Sell |
4,324
-86
| -2% | -$6.38K | 0.06% | 241 |
|
|
2019
Q3 | $278K | Buy |
4,410
+40
| +0.9% | +$2.52K | 0.06% | 259 |
|
|
2019
Q2 | $238K | Buy |
+4,370
| New | +$238K | 0.07% | 230 |
|
|
2019
Q1 | – | Sell |
-3,457
| Closed | -$227K | – | 265 |
|
|
2018
Q4 | $227K | Buy |
3,457
+387
| +13% | +$25.4K | 0.08% | 197 |
|
|
2018
Q3 | $242K | Buy |
+3,070
| New | +$242K | 0.07% | 236 |
|
|
2018
Q2 | – | Sell |
-5,244
| Closed | -$326K | – | 315 |
|
|
2018
Q1 | $326K | Sell |
5,244
-2,674
| -34% | -$166K | 0.09% | 218 |
|
|
2017
Q4 | $636K | Buy |
+7,918
| New | +$636K | 0.16% | 123 |
|